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SETTING:  Urban clinic, Nairobi.
OBJECTIVES: To evaluate the impact of specimen qual-
ity and different smear-positive tuberculosis (TB) case 
(SPC) defi  nitions on SPC detection by sex.
DESIGN:  Prospective study among TB suspects.
RESULTS: A total of 695 patients were recruited: 644 
produced ⩾1 specimen for microscopy. The male/female 
sex ratio was 0.8. There were no signifi  cant differences in 
numbers of men and women submitting three specimens 
(274/314 vs. 339/380, P = 0.43). Signifi  cantly more men 
than women produced a set of three ‘good’ quality speci-
mens (175/274 vs. 182/339, P = 0.01). Lowering thresh-
olds for defi  nitions to include scanty smears resulted in 
increases in SPC detection in both sexes; the increase was 
signifi  cantly higher for women. The revised World Health 
Organization (WHO) case defi   nition was associated 
with the highest detection rates in women. When analy-
sis was restricted only to patients submitting ‘good’ 
quality specimen sets, the difference in detection between 
sexes was on the threshold for signifi  cance (P = 0.05).
CONCLUSIONS: Higher SPC notifi  cation rates in men 
are commonly reported by TB control programmes. The 
revised WHO SPC defi  nition may reduce sex disparities 
in notifi  cation. This should be considered when evaluat-
ing other interventions aimed at reducing these. Further 
study is required on the effects of the human immuno-
defi  ciency virus and instructed specimen collection on 
sex-specifi  c impact of new SPC defi  nition.
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nosis; sex; gender; HIV
UNTIL NEW DIAGNOSTICS become available, 
global tuberculosis (TB) control will remain reliant on 
sputum smear microscopy.1 Smear microscopy is an 
insensitive technique, dependent upon large numbers 
of acid-fast bacilli (AFB) being present in sputum. 
However, a recently described mathematical model 
has indicated that considerable public health impact 
may accrue from improving patient access to a smear-
based diagnosis.2 In 2006, only 61% of the world’s 
predicted sputum smear-positive cases (SPCs) were 
detected.3
Until recently, international guidelines recom-
mended the examination of three sputum specimens 
for AFB in the investigation of suspected pulmonary 
TB. These guidelines defi   ned a positive smear as 
⩾10  AFB per 100 high-power microscopic fi  elds 
(HPF), and an SPC as a person with at least two 
positive smears.4–6 Smears containing few bacilli (1–
9 AFB/100 HPF) are termed ‘scanty’ smears. They are 
not uncommon, and can account for 10% of all 
smears from TB suspects presenting to microscopy 
centres.7 There is good evidence that among clinical 
TB suspects in endemic countries, scanty smears are 
indicative of true positivity.7,8
In a study conducted in Nairobi, our group showed 
that lowering the thresholds for defi  ning a positive 
smear to include scanty smears and for defi  ning an 
SPC to a single positive smear considerably increased 
the number of cases detected.9
The World Health Organization (WHO) recently 
changed its policy with respect to the defi  nitions of a 
positive smear from 10 AFB/100 HPF to 1 AFB per 
smear and an SPC from a patient with two positive 
smears to a patient with a single positive smear.10,11 
These changes are likely to increase the number of 
SPCs being diagnosed and/or notifi  ed.
In most countries, SPC notifi  cation rates are higher 
in men than in women.3 The reason for the disparate 
sex ratio is unclear, but is likely to be a complex mix-
ture of biological, epidemiological and socio-cultural 
determinants, compounded in some settings by inequi-
table access to health systems.12–22 It has been   reported 
that women are more likely than men to submit poor 
quality specimens.23,24 Specimen quality is a critical 
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determinant of smear microscopy performance, and 
poor quality specimens (as judged macroscopically) 
are associated with lower concentrations of AFB.25,26
It is important to understand whether recent changes 
in defi  nitions, in addition to increasing the total num-
ber of reported SPCs, may affect sex disparities in case 
detection. This is important to ensure that the evalua-
tion of other initiatives aimed at reducing sex dispari-
ties can be properly interpreted in the light of the 
changed defi  nitions.
We interrogated the data from the Nairobi study 
to determine: 1) whether women were more likely to 
submit poor quality specimens; 2) whether patients 
submitting poor quality specimens were more likely 
to benefi  t from the reduced thresholds; and 3) whether 
women, regardless of specimen quality, were more 
likely to benefi  t from the reduced thresholds.
STUDY POPULATION AND METHODS
The study was conducted in Mathare, Nairobi, be-
tween February and December 2005 in a clinic sup-
ported by the Kenyan Ministry of Health and Méde-
cins Sans Frontières. The study site and methods have 
been described previously.9 The clinic delivers TB-HIV 
(human immunodefi   ciency virus) care to the local 
community. In 2001, 50% of TB patients in Nairobi 
were estimated to be HIV co-infected.27 The clinic’s 
laboratory routinely performs sputum microscopy.
All consecutive patients aged ⩾15 years with cough 
>2 weeks were eligible for the study. After providing 
written informed consent, patients were interviewed 
regarding symptoms and medical history using a stan-
dard form/questionnaire. They were asked to submit 
three specimens over 2 consecutive days. Patients were 
coached by a dedicated technician in deep breathing 
and sputum expectoration following standard oper-
ating procedures. The on-the-spot specimens were 
collected out of doors under supervision.
The fi  rst specimen was collected on the spot at initial 
consultation, the second at home the following morn-
ing, and the third when the patient attended the clinic 
to deliver the second specimen. Patients submitting 
specimens of <1 ml in quantity were requested to pro-
duce others. Specimen appearance was assessed macro-
scopically. It was recognised that a mucoid or salivary 
specimen may not necessarily be a ‘poor’ specimen if 
the patient’s illness was not causing the production of 
purulent or mucopurulent sputum. The specimen qual-
ity was therefore defi  ned as ‘good’ if it was purulent, 
mucopurulent and/or blood-stained, and ‘pos  sibly 
poor’ in the case of mucoid and salivary specimens.
Smears were stained using the hot Ziehl-Neelsen 
(ZN) technique (carbol fuchsin 1% and 0.1% methy-
lene blue). Slides were examined at ×1000 magnifi  -
cation by two independent microscopists blind to the 
results of other specimens from the patient. Smears 
were considered negative if no AFB were seen in 
100 HPFs. Positive smears were graded in accordance 
with the WHO/International Union Against Tubercu-
losis and Lung Disease system.4,6 Where <10 AFB 
were seen in 100 HPFs, the exact number of AFB ob-
served in 100 HPF was recorded.
After laboratory investigation, patients were re-
ferred back to the clinicians and decisions to treat for 
TB were made based on smear microscopy result, 
clinical presentation and chest X-ray fi  ndings.
Inter- and intra-reader reliability was assessed on a 
sample of 200 smears, randomly selected to be blindly 
re-read by a second microscopist, or by the same mi-
croscopist after a 1-day interval. Slide identifi  cation 
was masked by opaque tape by the study supervisor to 
ensure blinding. Every month, the study supervisor re-
checked, blind, a random selection of 50–100% of pos-
itive and 10–20% of negative smears. At the end of the 
study, 100 randomly selected smears were examined 
blind at the TB laboratory of the Centre for Respira-
tory Disease Research, Kenya Medical Research Insti-
tute (KEMRI) as external quality assessment (EQA).
To assess sex differences in SPC detection, several 
approaches were compared. The approaches varied 
in the AFB cut-off used to defi  ne a positive smear, the 
number of positive smears required to defi  ne an SPC, 
and whether two or three specimens were examined. 
The approaches are presented in Table 1.
The proportion of TB suspects found to be SPCs 
was calculated for each approach and reported with a 
95% confi  dence interval (95%CI). The SPC rate of Ap-
proaches B, C, D and E were compared with the con-
ventional approach using McNemar’s test for matched 
data. Patients’ clinical characteristics, specimen qual-
ity and smear-positive detection rate were compared 
between males and females using χ2 and t-tests, re-
spectively, to compare proportions and means, and 
the rank sum test for non-normal distribution.
Inter- and intra-reader reliability was assessed by 
the calculation of the kappa (κ) coeffi  cient, which mea-
sures the degree to which the results of both tests vary 
when read by two independent readers, or by the same 
reader after a 1-day interval. A κ coeffi  cient of between 
0.80 and 1.00 signifi  es an almost perfect agreement.
Data were double-entered using EpiData 3.1 (Epi-
Data Association, Odense, Denmark) and analysed us-
Table 1  Approaches to assess sex differences in tuberculosis 
detection
Approach A At least 2 smear-positive results out of 3, both 
⩾10 AFB/100 HPF 
Approach B  At least 2 smear-positive results out of 3, one 
⩾10 AFB/100 HPF 
Approach C  At least 2 smear-positive results out of 3, both 
⩾1 AFB/100 HPF
Approach D At least 1 smear-positive result (⩾10 AFB/
100 HPF) in the 2 ﬁ  rst specimens collected
Approach E  At least 1 smear-positive result (⩾1 AFB/100 HPF) 
in the 2 ﬁ  rst specimens collected
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ing Stata/SE 9.1 (StataCorp LP, College Station, TX, 
USA).
The National Ethical Review Committee of KEMRI 
(Nairobi, Kenya) and the Comité de Protection des Per-
sonnes (Ile de France XI, France) approved the study.
RESULTS
A total of 695 suspected TB patients were included in 
the study and 644 could produce at least one sputum 
specimen (Figure). In total, 1879 specimens were ex-
amined. One patient’s sex was not recorded, 314 
(45.2%) were male, and 380 (54.7%) were female. 
The male/female sex ratio was 0.8. The median age 
was 30 years (interquartile range [IQR] 25–37). Males 
were older than females (median age 34.1 years, IQR 
26–  40 vs. 30 years, IQR 25–35, P < 0.001).
Past TB history, intake of antibiotics in the 2 weeks 
prior to specimen collection and patients’ clinical signs 
at presentation are reported in Table 2 for males and 
females, respectively. There were no signifi  cant differ-
ences between male and female patients in reported 
symptoms.
Among the 644 TB suspects able to produce at 
least one specimen, the sex ratio was also 0.8. There 
was no signifi  cant difference in the number of men 
and the number of women submitting three sputum 
specimens (274/314, 87.3% vs. 339/380, 89.2%, P = 
0.43). Purulent, mucopurulent (n = 1401) and blood-
stained (n = 56) specimens (i.e., ‘good’ quality speci-
mens) accounted for 77.5% of all specimens (1457/ 
1879), and mucoid (n = 414) and salivary (n = 8) 
specimens (i.e., ‘possibly poor quality’ specimens) for 
22.5% (422/1879). On the basis of this macroscopic 
classifi  cation, signifi  cantly more men than women pro-
duced a set of three ‘good’ quality specimens (175/274, 
63.9% vs. 182/339, 53.7%, P = 0.01). The propor-
tion of males and females who failed to submit any 
sputum specimens was not signifi  cantly  different, 
(8.6%, 27/314 vs. 6.3%, 24/380, P = 0.25).
Inter- and intra-reader reliability was very good, 
with a κ coeffi   cient of respectively 0.83 (95%CI 
0.76–0.86) and 0.91 (95%CI 0.88–0.94). Among the 
200 smears blindly and randomly selected for inter-
  observer reliability assessment, nine smears were 
Table 2  Patient characteristics at inclusion (N = 694)*
Male
(n = 314) 
n (%)
Female
(n = 380) 
n (%) P value
TB past history   60 (19.1)   64 (16.8) 0.44
Course of antibiotics 
  in past 2 weeks   17 (5.4)   25 (6.6) 0.1
Clinical presentation
Sputum production 314 (100) 380 (100) 1
Fever 288 (91.7) 349 (91.8) 0.95
Chest pain 291 (92.8) 346 (91.0) 0.44
Night sweats 275 (87.6) 316 (83.2) 0.10
Weight loss 111 (35.3) 148 (38.9) 0.33
Haemoptysis  57  (18.1)  56  (14.7) 0.22
Loss of appetite 223 (71.0) 294 (77.4) 0.06
* One patient with sex data missing from the original 695 recruited.
TB = tuberculosis.
Figure Study  proﬁ  le. ICF = informed consent form.
Table 3  Results of internal quality control by study supervisor
Month
2005
Smears
controller-
positive
n
Smears
controller-
negative
n
Total
n
Sensitivity
%
Speciﬁ  city
%
Errors by
controlled
microscopists
February   13  17  30 100 100  1  minor
March  45  31  76 100 100  2  minor
April  34  41  75 100 100  2  minor
May  36  41  77 100  95  2  major  (false-positive)
June  35  42  77 100  95  2  major  (false-positive)
July  31  38  69 100 100  2  minor
August  31  32  63 100 100  3  minor
September  52  24  76 100 100  1  minor
October  22  14  36 100 100  2  minor
November  28  18  46 100 100  1  minor
December  20  15  35 100 100  2  minor
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graded as scanty by the fi  rst observer. The second ob-
server graded six as scanty, one 1+ and two negative. 
Among the 200 smears blindly and randomly selected 
for intra-observer variation, six were graded as scanty 
on the fi  rst day by the observer. The same observer 
also graded these six smears as scanty on the follow-
ing day. In terms of smear positivity/negativity, inter-
nal quality control found 95–100% agreement be-
tween the study microscopist and the controller, and 
EQA agreement was 99% (Tables 3 and 4).9
The use of 1 AFB/100 HPF threshold to defi  ne a 
positive smear detected signifi   cantly more positive 
smears compared to the use of 10 AFB/100 HPF as 
threshold (19.9%, 374/1879 vs. 16.0%, 301/1879, 
P < 0.001). Table 5 presents positive smear detection 
rates in the group of ‘good’ and ‘possibly poor’ qual-
ity specimens. The detection rate was signifi  cantly 
higher for specimens of ‘good’ quality compared to 
those of ‘possibly poor’ quality, regardless of which 
AFB threshold was used. The increase in detection us-
ing a more sensitive threshold was signifi  cantly more 
important in the group of ‘possibly poor’ quality 
specimens (P = 0.004).
The standard approach (A) detected 105 SPCs 
among 644 TB suspects (16.3%). The proportions 
of TB suspects found to be SPCs by the different 
  approaches (A–E) are reported in Table 6 for men and 
women. They all detected signifi  cantly more SPCs than 
Approach A (P < 0.001). Regardless of the approach, 
signifi  cantly more men than women were found to be 
smear-positive. There were 20/45 (44.4%) and 10/59 
(16.9%) extra cases detected by Approach E com-
pared to Approach A in women and men, respectively. 
The increase in detection was signifi  cantly higher for 
women (P < 0.002). When we selected only patients 
Table 4  Results of external quality assessment by 
Tuberculosis Laboratory, KEMRI, Nairobi, Kenya*
Controller
(KEMRI)
Controlled microscopists
Negative Scanty 1+ 2+ 3+ Total
Negative 83 1  0  0 0  84
Scanty  0 3  2  0 0   5
1+  00 8  20 1 0
2+  00 1  93 1 3
3+  00 0  26  8
Total 83 4 11 13 9 120
* Total number of errors = 11 minor errors.
KEMRI = Kenya Medical Research Institute.
Table 5  Smear-positive results according to specimen quality (N = 1879)
Purulent, mucopurulent 
and blood-stained
(n = 1457)
Mucoid and salivary
(n= 422)
n % (95%CI) n % (95%CI) P value Total
⩾10 AFB/100 HPF 267 18.3 (16.4–20.4) 34   8.1 (5.6–11.1) <0.001 301
⩾1 AFB/100 HPF 325 22.3 (20.2–24.5) 49 11.6 (8.7–15.1) <0.001 374
Increase in detection   58 21.7 15 44.1 0.004
CI = conﬁ  dence interval; AFB = acid-fast bacilli; HPF = high power microscopic ﬁ  eld.
Table 6  Proportion of TB suspects found to be SPCs using different approaches to deﬁ  ne an SPC (difference of positivity rate 
between male and female)*
Total
(N = 644)†
Female
(n = 356)
Male
(n = 287)
n % (95%CI) n % (95%CI) n % (95%CI) P value
Approach A 105 16.3 (13.5–19.4) 45 12.6 (9.4–16.5) 59 20.6 (16.0–25.7) 0.007 
Approach B 116 18.0 (15.1–21.2) 52 14.6 (11.1–18.7) 63 21.9 (17.3–27.2) 0.006
Approach C 126 19.6 (16.6–22.8) 58 16.3 (12.6–20.5) 67 23.3 (18.6–28.7) 0.01
Approach D 117 18.2 (15.3–21.4) 54 15.2 (11.6–19.3) 62 21.6 (17.0–26.8) 0.03
Approach E 135 21.0 (17.9–24.3) 65 18.3 (14.4–22.7) 69 24.0 (19.2–29.4) 0.03
* Comparison between different approaches: A vs. B, P ⩽ 0.01; A vs. C, P ⩽ 0.01; A vs. D, P ⩽ 0.01; A vs. E, P ⩽ 0.01.
† One patient with sex data missing.
SPC = smear-positive TB case; CI = conﬁ  dence interval; TB = tuberculosis.
Table 7  Proportions of SPCs found among male and female 
tuberculosis suspects able to produce a set of three ‘good’ 
quality specimens and two ‘good’ quality specimens for 
approaches based on collection of three and two specimens, 
respectively (difference of positivity rate between males and 
females)
Females Males 
n % (95%CI) n % (95%CI) P value 
Three specimens  (n = 182) (n = 175)
Approach A 32 17.6 (12.3–23.9) 45 25.7 (19.4–32.8) 0.06
Approach B 34 18.7 (13.3–25.1) 48 27.4 (21.0–34.7) 0.05
Approach C 37 20.3 (14.7–26.9) 51 29.1 (22.5–36.5) 0.05
Two specimens  (n = 218) (n = 201)
Approach D 39 18.0 (13.0–23.6) 52 25.9 (20.0–32.5) 0.05
Approach E 46 21.1 (15.9–27.1) 59 29.3 (23.2–36.2) 0.05
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who were able to produce a set of ‘good’ quality spec-
imens, the difference in detection between men and 
women was on the threshold for signifi  cance (P = 
0.05). Table 7 shows the proportion of TB suspects 
found to be SPCs among males and females able to 
produce a set of three ‘good’ quality specimens and 
two ‘good’ quality specimens for approaches based 
on the collection of three and two specimens, 
respectively.
HIV status was not determined for all patients, but 
153/696 (22.0%) were HIV-infected patients referred 
for TB investigation by the HIV clinic. Signifi  cantly 
more women than men had been referred (107/380, 
28.2% vs. 46/314, 14.6%, P < 0.001).
DISCUSSION
This study suggests that using lower thresholds to de-
fi  ne positive smears and SPCs may also result in a re-
duction in the sex disparities seen in SPC notifi  cations 
in some settings. This is achieved primarily through 
increased fi  nding of positive smears in ‘possibly poor’ 
quality specimens.
Our fi   ndings indicate that: 1) men and women 
were both signifi  cantly more likely to be classifi  ed as 
SPCs using the reduced thresholds; 2) patients sub-
mitting ‘possibly poor’ quality specimens were signifi  -
cantly more likely to be classifi  ed as SPCs using the 
reduced thresholds; 3) women were signifi  cantly more 
likely than men to produce ‘possibly poor’ quality 
specimens; and 4) although women were signifi  cantly 
more likely than men to be classifi  ed as smear-positive 
using the reduced threshold, this sex- or gender-
  specifi  c effect may not be signifi  cant when ‘possibly 
poor’ quality specimens were removed from the anal-
ysis (P = 0.05).
Lowering the thresholds for defi   ning a positive 
smear to include scanty smears, and the threshold for 
defi  ning an SPC to a single positive smear, consider-
ably increased the number of cases detected.9 The 
considerable increase in the number of cases detected 
could be achieved even when reducing the number of 
specimens examined from three to two, thus reducing 
the laboratory workload and, potentially, the number 
of patient visits required.9 Reducing the workload 
could help increase case detection by allowing more 
time for the examination of smears.28,29 Reducing the 
number of patient visits required could help increase 
case detection through reducing patient drop-out 
during the diagnostic investigation. TB suspect drop-
out rates of between 13% and 95% during the diag-
nostic process have been reported.30,31
Smear microscopy is dependent upon relatively 
large numbers of AFB being present in the sputum. 
Paucibacillary pulmonary TB leading to smear-
  negative results is common where rates of TB-HIV co-
morbidity are high, due most likely to altered patho-
logical processes in the immunocompromised host.32 
Any sex/gender disparities in HIV prevalence are likely 
to be refl  ected in TB notifi  cation due to the associa-
tion of HIV with a reduced probability of smear-
based diagnosis.
There may be other reasons for the under-notifi  ca-
tion of female SPCs. A study in Kenya that reported a 
lower sensitivity of ZN microscopy in women found 
that it was not signifi  cantly lower in women (after ad-
justment for HIV).22 Interestingly, in the same study, 
the use of fl  uorescence microscopy—recently shown to 
be 10% more sensitive on average than ZN m icroscopy 
—reduced the sex differences.22,33
Absence, or reduced numbers, of AFB in sputum 
can be due to poor quality specimens.25,26 Undernoti-
fi  cation of female SPCs may be expected if women 
are less likely to produce ‘good’ quality sputum 
specimens.23,24
Improving the specimen quality by providing pa-
tients with clear sputum collection instructions has 
been reported to markedly increase the sensitivity of 
ZN microscopy.23,34 A recent study in Pakistan re-
ported that such instructions reduced the frequency 
of submission of poor quality specimens and substan-
tially increased the number of women being consid-
ered SPCs (in accordance with the previous WHO 
defi  nition).23 The large increase in sensitivity could 
not be explained wholly through the increased sub-
mission of higher quality sputum specimens.23 The 
effect of instruction on smear positivity in men was 
less, and was not statistically signifi  cant.23
There were limitations associated with our study. 
First, sputum quantity was not recorded. Sputum 
quantity may be important: in this study, 51 patients 
were excluded because they could not produce spu-
tum specimens of at least 1 ml. The quantity of speci-
men (above the minimum 1 ml) submitted by patients 
was not recorded. It has been reported that in the ab-
sence of instruction, men submit larger volume speci-
mens and that specimens of at least 5 ml have a higher 
probability of testing smear-positive.23,35 However, a 
study in Kenya reported no signifi  cant difference be-
tween the sexes in the volume of specimen submitted 
(Professor Paul Klatser, personal communication), and 
found that specimen volume was associated with nei-
ther smear nor culture positivity.22 Second, HIV sta-
tus was not determined for all subjects. Signifi  cantly 
more of the female patients recruited had been referred 
from the HIV clinic and were known to be HIV-
  infected. The effect of HIV co-infection on the rate of 
submission of ‘possibly poor’ quality specimens needs 
further investigation. Finally, sputum samples were 
not cultured.
CONCLUSIONS
It is clear from this study that, even where patients 
are well-instructed in sputum collection and where 
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of thresholds for defi  ning a positive smear and an 
SPC results in more patients, particularly more female 
patients, being considered smear-positive cases.
The effects of HIV co-infection, coaching in speci-
men production, specimen volume and fl  uorescence 
microscopy on the sex- or gender-specifi  c impact of 
reduced thresholds for case defi  nition require further 
study. Studies should also look at whether lowering 
the thresholds for defi  ning an SPC results in more pa-
tients receiving treatment for TB, or whether the in-
crease in SPCs detected is only of signifi  cance in noti-
fi   cation and the monitoring and evaluation of TB 
control activities.
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CONTEXTE :  Une clinique urbaine de Nairobi, Kenya.
OBJECTIFS :  Evaluer l’impact de la qualité des crachats 
et de différentes défi  nitions de cas de tuberculose (TB) à 
frottis positifs (SPC) sur le taux de détection de SPC chez 
les hommes et les femmes.
MÉTHODE :  Etude prospective parmi les patients sus-
pects de TB.
RÉSULTATS :  Un total de 695 patients ont été recrutés : 
644 ont produit >1 spécimen pour l’examen microsco-
pique. Le sex-ratio (homme/femme) était de 0,8. Il n’y a 
pas eu de différence signifi  cative entre les hommes et les 
femmes pouvant soumettre trois spécimens (274/314 vs. 
339/380 ; P = 0,43). Signifi  cativement plus d’hommes 
que de femmes (175/274 vs. 182/339 ; P = 0,01) ont 
soumis un lot de trois échantillons de « bonne » qualité. 
La réduction des seuils de positivité pour défi  nir un SPC 
en incluant les frottis faiblement positifs («  scanty  ») 
s’est accompagnée d’une augmentation de la détection 
de SPC chez les hommes et les femmes. L’augmentation 
a été signifi  cative chez les femmes. La défi  nition révisée 
du SPC de l’Organisation Mondiale de la Santé (OMS) 
s’est accompagnée de la meilleure proportion de SPC 
chez les femmes. Quand l’analyse se limite aux patients 
ayant soumis un lot de spécimens de « bonne » qualité, 
la différence de détection entre les hommes et les femmes 
a été à la limite de la signifi  cation statistique (P = 0,05).
CONCLUSIONS :  Des  taux de SPC supérieurs chez les 
hommes sont classiquement décrits. La révision de défi  ni-
tion de l’OMS du cas peut réduire la disparité de notifi  ca-
tion de SPC entre les hommes et les femmes, et ceci est à 
prendre en compte pour l’évaluation d’autres interven-
tions visant à réduire cette disparité. Les effets de la co-
infection par le virus de l’immuno  défi  cience humaine et 
de l’accompagnement pour la collecte des crachats, sur 
l’impact de la réduction des seuils de positivité pour dé-
fi  nir un SPC chez les hommes et les femmes doivent en-
core être étudiés.
MARCO DE REFERENCIA  :  Un consultorio urbano en 
Nairobi, Kenia.
OBJETIVOS :  Evaluar la repercusión de la calidad de la 
muestra de esputo y de las diferentes defi  niciones de caso 
de tuberculosis (TB) con baciloscopia positiva (SPC), 
sobre la detección de tales casos en hombres y mujeres.
MÉTODOS :  Fue este un estudio prospectivo de pacientes 
con presunción clínica de TB.
RESULTADOS :  Se incluyeron en el estudio 695 pacien-
tes, de los cuales 644 aportaron como mínimo una mues-
tra de esputo para estudio microscópico. El cociente en-
tre hombres y mujeres fue de 0,8. No se observó una 
diferencia estadísticamente signifi  cativa entre los hom-
bres y las mujeres que aportaron tres muestras (274/314 
vs. 339/380  ; P =  0,43). Más hombres que mujeres 
aportaron tres muestras de ‘buena calidad’ (175/274 vs. 
182/339 ; P = 0,01).   Cuando se bajó el umbral de la de-
fi  nición de SPC y se incluyeron las muestras con escasos 
bacilos, se observó una mayor detección de casos en 
ambos sexos. El aumento de la detección fue signifi  cati-
vamente mayor en las mujeres. La defi  nición de SPC re-
visada de la Organización Mundial de la Salud (OMS) se 
asoció con las tasas más altas de detección en las mujeres. 
Cuando se restringió el análisis a los pacientes que apor-
taron varias muestras de buena calidad, la diferencia en 
la detección de casos entre hombres y mujeres alcanzó 
apenas el nivel de signifi  cación estadística (P = 0,05).
CONCLUSIONES :  Es frecuente una mayor tasa de notifi  -
cación de SPC en los hombres. La defi  nición revisada 
puede disminuir las diferencias de notifi  cación entre los 
sexos. Es importante considerar este aspecto cuando se 
evalúan otras intervenciones cuyo objetivo es reducir 
estas discrepancias. Es necesario estudiar con más de-
tenimiento los efectos de la coinfección por el virus de 
la inmunodefi  ciencia humana y las indicaciones sobre la 
recogida del esputo, en la repercusión, específi  ca de gé-
nero, de la disminución del umbral de número de bacilos 
en defi  nición de caso.
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